Biolinerx Ltd.
13F holders, Q4 2024 (December 31)30holders −2
9new positions
12sold out
1famous investor
$0.21avg. 13F price*
At the end of Q4 2024, 30 institutions reported holding Biolinerx Ltd. in their 13F filings, down 2 from Q3 2024. 9 opened new positions and 12 sold out. The largest holders were Highbridge Capital Management LLC ($215K), Values First Advisors, Inc. ($36K) and Atria Wealth Solutions, Inc. ($20K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biolinerx Ltd.
- CUSIP
- 09071M205
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $258K |
| Exits | 12 | $872K |
All 13F filers, Q3 2024 → Q4 2024: 1,322,958 shares bought and 1,838,580 shares sold, net −515,622 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Highbridge Capital Management LLC | 0.03% | New | 1,010,012 | $215K |
| Values First Advisors, Inc. | 0.02% | Reduce -15.7% | 166,449 | $36K |
| Atria Wealth Solutions, Inc. | 0.00% | No change | 94,133 | $20K |
| LPL Financial LLC | 0.00% | No change | 92,000 | $20K |
| Susquehanna International Group, LLP | 0.00% | Add +383.7% | 87,215 | $19K |
| Morgan Stanley | 0.00% | Reduce -60.0% | 79,102 | $17K |
| BNP Paribas Financial Markets | 0.00% | New | 57,340 | $12K |
| Rhumbline Advisers | 0.00% | Add +31.7% | 42,961 | $9K |
| Gradient Investments LLC | 0.00% | Add +38.0% | 41,400 | $9K |
| Geode Capital Management, LLC | 0.00% | No change | 39,993 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 35,310 | $8K |
| Rathbones Group PLC | 0.00% | Reduce -20.5% | 31,666 | $7K |
| Citigroup Inc. | 0.00% | New | 31,337 | $7K |
| Watts Gwilliam & Co., LLC | 0.00% | New | 34,000 | $5K |
| Royal Bank of Canada | 0.00% | New | 20,200 | $4K |
| Citadel Advisors | 0.00% | New | 15,314 | $3K |
| Creative Planning | 0.00% | No change | 12,982 | $3K |
| Nemes Rush Group LLC | 0.00% | No change | 12,000 | $3K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -8.4% | 11,935 | $3K |
| Weaver Consulting Group | 0.00% | Reduce -63.0% | 11,000 | $2K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 10,500 | $2K |
| Hibernia Wealth Partners, LLC | 0.00% | New | 10,000 | $2K |
| Neville Rodie & Shaw Inc. | 0.00% | New | 10,000 | $2K |
| UBS Group AG | 0.00% | Add +834.5% | 9,196 | $2K |
| Wells Fargo & Company | 0.00% | Reduce -84.2% | 5,535 | $1K |
| Geneos Wealth Management Inc. | 0.00% | Add +6.7% | 4,800 | $1K |
| NewEdge Advisors, LLC | 0.00% | No change | 4,300 | $920 |
| SBI Securities Co., Ltd. | 0.00% | — | 3,104 | $664 |
| Osaic Holdings, Inc. | 0.00% | No change | 1,206 | $258 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 200 | $43 |
"% of holder's portfolio" is BIOLINERX LTD's weight in each manager's 13F, not the share of Biolinerx Ltd. the manager owns.